Searched for
PHARMACEUTICAL MARKETING PRACTICES MANDATORY
Delhi government mulls mandatory fire safety norms for low-rise residential buildingsDelhi government is looking at making fire safety devices like smoke detectors and extinguishers compulsory in smaller homes. This move fol...- India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
- Cancer drug prices raised 50% as NPPA acts on shortage concernsIndia's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...
- Two Trades for Today: 2 pharma companies – a large-cap for a 5% rise, and a mid-cap stock for a gain of 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Nepal clarifies: No ban on Indian mango imports, only phytosanitary measures enforcedPhytosanitary standards, including mandatory heat treatment, are in place, and import permits continue to be issued for shipments meeting t...
- Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
- Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...
- Piyush Goyal meets Ernst & Young CEO, discusses India's role in global supply chainsUnion Minister Piyush Goyal said he held a meeting with Janet Truncale, Global Chair and CEO of EY, to discuss India's growing role in glob...
- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- India willing to open its market to high-quality, innovative pharma products, says commerce ministerIndia is ready to welcome high-quality global pharmaceutical products. This move is in exchange for better market access for Indian drug ex...
- Regulator, cos discuss price hike for some cancer drugsIndia's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...
- Remember I amA simple yet powerful technique is presented. It involves remembering 'I am' constantly while performing daily tasks. This self-remembering...
- 'Direct contradiction of CBSE governing body's own decision': Jairam Ramesh raises concerns over introducing third language in schoolsCongress leader Jairam Ramesh has urged the government to withdraw a new notification. This notification makes a third language compulsory ...
- Russia-India business dialogue at SPIEF: Energy, transport, information technology, science & education in focusRussia and India convened at SPIEF to boost economic ties. Discussions focused on joint projects in energy, transport, IT, science, and edu...
- Drug companies directed to step up vigil on adverse reactionsIndia's drug regulator, CDSCO, has mandated all drug companies to establish systems for tracking adverse drug reactions. This move comes am...
- Pharma exports to US seen muted this yearIndian pharma exports to the US face a subdued outlook this year. Policy uncertainties, falling generic prices, and regional conflicts are ...
- CCPA slaps fines on PhysicsWallah, McAfee for 'Dark Pattern' practicesIndia's consumer watchdog has fined edtech firm PhysicsWallah and cybersecurity company McAfee. They were found using deceptive interface d...
- Over 60% of pharma MSMEs yet to comply with updated manufacturing normsPharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...
- Trump administration proposes 25% tariff to punish Brazil over trade practicesThe United States is proposing a 25% tariff on many imports from Brazil. This action follows an investigation into unfair trade practices. ...
Load More
